JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259111

Human SHC3 (SHCC) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SHC3 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 20 bp deletion in exon4.
1 Images
Sanger Sequencing - Human SHC3 (SHCC) knockout HeLa cell lysate (AB259111)
  • Sanger seq

Unknown

Sanger Sequencing - Human SHC3 (SHCC) knockout HeLa cell lysate (AB259111)

Homozygous : 20 bp deletion in exon4

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 20 bp deletion in exon4.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259111-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SHC3 knockout HeLa cell lysate", "number":"AB259111-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259111-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SHC3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SHC3 also known as SHCC is an adapter protein with a molecular weight approximately 55 kDa. It plays a significant role in signal transduction pathways by mediating interactions between activated tyrosine kinases and downstream molecules. SHC3 contains typical SH2 and PTB domains which allow it to bind phosphotyrosine residues on activated receptors. This protein is mainly expressed in the neural tissues suggesting a role in nervous system functions.
Biological function summary

SHC3 acts as a mediator in the signaling pathways that regulate cell proliferation differentiation and survival. It forms part of multi-protein complexes involved in transducing signals from the cell surface to the nucleus. Upon activation SHC3 interacts with various signaling proteins to propagate essential cellular signals that contribute to neuronal development and function. These interactions highlight its importance in maintaining cellular communication within neural environments.

Pathways

SHC3 is intricately involved in the MAPK/ERK pathway and PI3K/AKT pathway both critical for cell survival and growth. In the MAPK/ERK pathway SHC3 links receptors like Trk to downstream effectors facilitating signal transmission. It also interacts with important proteins such as Grb2 and Ras serving as a scaffold to support signaling cascades that regulate neural cell function. Through these pathways SHC3 plays an integral part in linking external cellular cues to fine-tune intracellular responses.

SHC3 has connections to neurodegenerative disorders and cancer. Abnormal activity or expression of SHC3 may contribute to neurodegenerative diseases by disrupting normal signal transduction in neurons. Additionally in certain cancers altered SHC3 signaling can influence tumor growth and survival by interacting with proteins such as PI3K. Understanding SHC3's role in these conditions could advance therapeutic strategies targeting aberrant signaling pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com